|
⚲
|
| Keyboard |
| Somaiya Mayur Ian
✚
|
|
|---|---|
| CIK # | 0001760303 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001760303] | |
| 4 | [0001760303] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NewAmsterdam Pharma Co NV | |
| Somaiya Mayur Ian | |
| TCR2 Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-21 | Sell | 24,362 | $33.80 | 823,436 |
|
NewAmsterdam Pharma Co NV NAMS
Option (Right to Buy) · derivative
|
2026-01-21 | Option exercise | 39,784 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-21 | Option exercise | 39,784 | $9.26 | 368,400 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-21 | Sell | 15,422 | $33.25 | 512,782 |
|
NewAmsterdam Pharma Co NV NAMS
Option (Right to Buy) · derivative
|
2026-01-20 | Option exercise | 60,216 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-20 | Option exercise | 60,216 | $9.26 | 557,600 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-20 | Sell | 19,604 | $32.38 | 634,778 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-20 | Sell | 39,712 | $31.78 | 1,262,047 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-20 | Sell | 900 | $30.64 | 27,576 |
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-01-07 | Grant | 115,000 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-07 | Grant | 25,500 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-05 | Sell | 5,118 | $33.25 | 170,174 |
|
NewAmsterdam Pharma Co NV NAMS
Option (Right to Buy) · derivative
|
2025-01-28 | Option exercise | 14,900 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-01-28 | Sell | 3,405 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-01-28 | Sell | 11,495 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-01-28 | Option exercise | 14,900 | $9.26 | 137,974 |
|
NewAmsterdam Pharma Co NV NAMS
Option (Right to Buy) · derivative
|
2025-01-27 | Option exercise | 46,983 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-01-27 | Sell | 33,679 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-01-27 | Option exercise | 46,983 | $9.26 | 435,063 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-01-27 | Sell | 13,304 | ||
| showing 20 of 35 most recent transactions | |||||